J Liver Cancer.  2016 Sep;16(2):129-133. 10.17998/jlc.2016.16.2.129.

A Case of Management for Hepatocellular Carcinoma with Lung Metastasis

• Jeon HJ
• Kim TH
• Um SH
• Seo YS
• Kim HS
• Lim KJ
• Park SW
• Lee HA
• Kim DS

• KMID: 2357343
• DOI: http://doi.org/10.17998/jlc.2016.16.2.129

Abstract

Liver cancer is the 2nd most common cause of cancer related death in Korea. Especially, patients who present extrahepatic spread of hepatocellular carcinoma (HCC) have a shorter life expectancy (50% survival at 1 year and less than 4 months of median overall survival). Molecular target agent like sorafenib was usually mentioned as a treatment for them, but that was still not firmly established. We present a 75 year-old who had expanding nodular type of HCC. The mass was removed by resection and radiofrequency ablation. However, lung metastasis were revealed shortly after surgery. That lesions were treated with lenvatinib and systemic chemotherapy.

Keyword

Hepatocellular carcinoma; Metastasis; Molecular targeted therapy; Chemotherapy

MeSH Terms

Carcinoma, Hepatocellular*
Catheter Ablation
Drug Therapy
Humans
Korea
Life Expectancy
Liver Neoplasms
Lung*
Molecular Targeted Therapy
Neoplasm Metastasis*